Pharmacologic therapy for medical disorders during pregnancy

Clinical Obstetrics and Gynecology

Volumn 45, Issue 1, 2002, Pages 136-152

  Hansen, Wendy F ^a   Yankowitz, Jerome ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIASTHMATIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; ANXIOLYTIC AGENT; BECLOMETASONE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DOPAMINE RECEPTOR BLOCKING AGENT; FLUNISOLIDE; FLUTICASONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE; PIRBUTEROL; PSYCHOTROPIC AGENT; SALBUTAMOL; SEROTONIN AGONIST; TERBUTALINE; TRIAMCINOLONE; UNINDEXED DRUG; VITAMIN;

ADULT; ASTHMA; DEEP VEIN THROMBOSIS; DRUG USE; EPILEPSY; FETOTOXICITY; FETUS; FETUS MALFORMATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; MIGRAINE; PHARMACEUTICAL CARE; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

ANTI-ASTHMATIC AGENTS; ANTIDEPRESSIVE AGENTS; ASTHMA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASES; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, HEMATOLOGIC; VIRUS DISEASES;

EID: 0036192744     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200203000-00014     Document Type: Review

References (77)

1. Teratology and the epidemiology of birth defects: Occupational and environmental perspectives
2. Human teratology
3. Effects of therapeutic, diagnostic, and environmental agents
4. Clinical teratology
5. FDA Classification of drugs for teratogenic risk
6. Drugs during pregnancy: An issue of risk classification and information to prescribers
7. Report of the teratology society public affairs committee symposium on FDA classification of drugs
8. The fate of drugs in pregnancy
9. Pregnancy delays paracetamol absorption and gastric emptying in patients undergoing surgery
10. Pharmacokinetics of digoxin in pregnancy
11. Gender effects in pharmacokinetics and pharmacodynamics
12. The safety of asthma and allergy medications during pregnancy
13. Asthma and pregnancy
14. Asthma and pregnancy
15. The course of asthma in pregnancy, post-partum, and with successive pregnancies: A prospective analysis
16. Asthma and pregnancy: A prospective study of 198 pregnancies
17. Databases in the assessment of the effect of drugs during pregnancy
18. Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies
19. Maternal corticosteroid use and risk of selected congenital anomalies
20. Morning sickness control in early pregnancy by Neiguan point acupressure
21. Acupressure for nausea and vomiting of pregnancy: A randomized blinded study
22. Alternative therapies for nausea an vomiting of pregnancy
23. Ginger treatment of hyperemesis gravidarum
24. Ginger for nausea and vomiting in pregnancy: Randomized, double-masked, placebo-controlled trial
25. Interventions for nausea and vomiting in early pregnancy
26. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy
27. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid
28. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy
29. Session 10: Drug treatment of rheumatic diseases during pregnancy. The teratogenicity of antirheumatic drugs-what is the evidence?
30. Depression in women
31. Pharmacologic management of psychiatric illness during pregnancy: Dilemmas and guidelines
32. Pharmacologic treatment of psychiatric disease in pregnancy and lactation: Fetal and neonatal effects
33. Excretion of bupropion in breast milk
34. Effectiveness of St John's wort in major depression
35. Prospective multicenter study of pregnancy outcome after lithium exposure during the first trimester
36. Management of herpes in pregnancy
37. Consequences of varicella and herpes zoster in pregnancy: Prospective study of 1739 cases
38. Prevention and control of influenza-recommendations of the Advisory committee on Immunization Practices
39. Public Health Service Task Force. Recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States
40. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
41. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women
42. Hepatitis B vaccine in pregnancy: Maternal and fetal safety
43. Pregnancy-related mortality in the United States, 1987-1990
44. Thrombosis in pregnancy: Maternal and fetal issues
45. Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy
46. Pregnancy through a prosthetic heart valve
47. Pregnancy and delivery of a patient with Starr-Edwards mitral valve Prosthesis
48. Maternal and fetal sequelae of anticoagulation during pregnancy
49. Risks to the fetus of anticoagulant therapy during pregnancy
50. Low-molecular-weight heparins
51. Low-molecular-weight heparins in pregnancy
52. Inherited thrombophilia and pregnancy: The obstetric perspective
53. Pharmacokinetic profile of a low-molecular-weight heparin (reviparin) in pregnant patients. A prospective cohort study
54. Use of low molecular weight heparin in pregnancy
55. Epilepsy and Pregnancy
56. Drugs in pregnancy: Anticonvulsants
57. Maternal and fetal implications of anticonvulsant therapy during pregnancy
58. The teratogenicity of anticonvulsant drugs
59. The new antiepileptic drugs and women: Efficacy, reproductive health, pregnancy and fetal outcome
60. Pregnancy, teratogenesis, and epilepsy
61. Consensus guidelines: Preconceptional counseling, management, and care of the pregnant woman with epilepsy
62. The fetal hydantoin syndrome
63. Spina bifida in infants of women treated with carbamazepine during pregnancy
64. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: A pharmaceutical company commitment
65. Classification and diagnostic criteria for headache disorders, cranial neuralgia, and facial pain
66. Diagnosis and classification of headache
67. Migraine: Diagnosis and treatment
68. Prevalence of migraine in the United States
69. Migraine and pregnancy
70. Headaches and women: Treatment of the pregnant and lactating migraineur
71. Drugs in pregnancy